High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B

BACKGROUND/AIMS: Newly developed and potent antiviral agents suffer from the problem of drug resistance. Multidrug resistance is a major impediment in the treatment of patients with chronic hepatitis B (CHB). In line with American Association for the Study of Liver Diseases guidelines, adefovir dipi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chae, Hee Bok, Kim, Mee Jin, Seo, Eui Geun, Choi, Yong Hyeok, Lee, Hee Seung, Han, Joung Ho, Yoon, Soon Man, Park, Seon Mee, Youn, Sei Jin
Format: Artigo
Idioma:Inglês
Publicat: The Korean Association for the Study of the Liver 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3326991/
https://ncbi.nlm.nih.gov/pubmed/22511906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/kjhep.2012.18.1.75
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars